These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37796703)

  • 21. Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma.
    Yeh CF; Chan TC; Ke HL; Chen TJ; Wu LC; Lee HY; Wei YC; Wu WJ; Li CF; Li WM
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of SLITRK6 gene as a potential therapeutic target for urothelial carcinoma in particular upper tract cancer.
    Mir MA; Pandith AA; Mansoor S; Baba SM; Makhdoomi R; Ain QU; Anwar I; Para SA; Bhat AH; Koul AM; Manzoor U; Khan I; Beg A; Wani MS
    Gene; 2023 Aug; 878():147583. PubMed ID: 37353040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma.
    Liang PI; Wei YC; Chen HD; Ma YC; Ke HL; Chien CC; Chuang HW
    Kaohsiung J Med Sci; 2024 Mar; 40(3):269-279. PubMed ID: 38180299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of
    Lai CC; Chen TJ; Chan TC; Li WS; He HL
    Future Oncol; 2021 Nov; 17(31):4145-4156. PubMed ID: 34467778
    [No Abstract]   [Full Text] [Related]  

  • 25. The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis.
    He J; Dong C; Zhang H; Jiang Y; Liu T; Man X
    Cell Signal; 2023 Feb; 102():110527. PubMed ID: 36410635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma.
    Chuang HW; Hsia KT; Liao JB; Yeh CC; Kuo WT; Yang YF
    Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma.
    Chan TC; Wu WJ; Li WM; Shiao MS; Shiue YL; Li CF
    Theranostics; 2020; 10(25):11775-11793. PubMed ID: 33052246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High TNFAIP6 level is associated with poor prognosis of urothelial carcinomas.
    Chan TC; Li CF; Ke HL; Wei YC; Shiue YL; Li CC; Yeh HC; Lee HY; Huang SK; Wu WJ; Li WM
    Urol Oncol; 2019 Apr; 37(4):293.e11-293.e24. PubMed ID: 30595463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
    Fan EW; Li CC; Wu WJ; Huang CN; Li WM; Ke HL; Yeh HC; Wu TF; Liang PI; Ma LJ; Li CF
    J Urol; 2015 Jul; 194(1):223-9. PubMed ID: 25623741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.
    Chang IW; Liang PI; Li CC; Wu WJ; Huang CN; Lin VC; Hsu CT; He HL; Wu TF; Hung CH; Li CF
    Tumour Biol; 2015 Jul; 36(7):5441-50. PubMed ID: 25934334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
    Yang J; Fan L; Liao X; Cui G; Hu H
    Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Lin VC; He HL; Hsu CT; Li CC; Wu WJ; Huang CN; Wu TF; Li CF
    Am J Transl Res; 2015; 7(4):710-22. PubMed ID: 26064439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.
    Chan TC; Hsing CH; Shiue YL; Huang SK; Hsieh KL; Kuo YH; Li CF
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder.
    Chang IW; Wang YH; Wu WJ; Liang PI; Li WM; Yeh BW; Wu TF; He HL; Huang SK; Li CF
    J Cancer; 2016; 7(3):304-13. PubMed ID: 26918044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma.
    Li CF; Chan TC; Pan CT; Vejvisithsakul PP; Lai JC; Chen SY; Hsu YW; Shiao MS; Shiue YL
    Cell Oncol (Dordr); 2021 Oct; 44(5):1133-1150. PubMed ID: 34339014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of replication protein A3 is associated with unfavorable outcome in bladder urothelial carcinoma.
    Sun D; Zhang K; Fu Q; Zhang H; Liu S; Wang H; Xu Z; Wang J
    J Cancer Res Ther; 2021 Jul; 17(3):771-776. PubMed ID: 34269312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
    Chan TC; Pan CT; Hsieh HY; Vejvisithsakul PP; Wei RJ; Yeh BW; Wu WJ; Chen LR; Shiao MS; Li CF; Shiue YL
    Cell Oncol (Dordr); 2023 Aug; 46(4):933-951. PubMed ID: 36920729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of lactate dehydrogenase B subunit expression is correlated with tumour progression and independently predicts inferior disease-specific survival in urinary bladder urothelial carcinoma.
    Liao AC; Li CF; Shen KH; Chien LH; Huang HY; Wu TF
    Pathology; 2011 Dec; 43(7):707-12. PubMed ID: 22027740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy.
    Takemoto K; Hayashi T; Hsi RS; Kobatake K; Sekino Y; Kitano H; Ikeda K; Goto K; Hieda K; Sentani K; Kajiwara M; Nishizaka T; Teishima J; Oue N; Hinata N
    Urol Oncol; 2022 Dec; 40(12):539.e9-539.e16. PubMed ID: 36244916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
    Wu K; Liu X; Wang Y; Wang X; Li X
    Front Public Health; 2022; 10():994351. PubMed ID: 36388369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.